Logo image of STMPA.PA

STMICROELECTRONICS NV (STMPA.PA) Stock Fundamental Analysis

Europe - EPA:STMPA - NL0000226223 - Common Stock

22.185 EUR
-0.09 (-0.38%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

4

STMPA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 54 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and the financial health of STMPA get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, STMPA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

STMPA had positive earnings in the past year.
STMPA had a positive operating cash flow in the past year.
In the past 5 years STMPA has always been profitable.
STMPA had a positive operating cash flow in each of the past 5 years.
STMPA.PA Yearly Net Income VS EBIT VS OCF VS FCFSTMPA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.42%, STMPA is doing worse than 68.52% of the companies in the same industry.
STMPA has a Return On Equity of 4.84%. This is in the lower half of the industry: STMPA underperforms 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.12%, STMPA is doing worse than 70.37% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for STMPA is above the industry average of 15.12%.
The last Return On Invested Capital (3.12%) for STMPA is well below the 3 year average (17.60%), which needs to be investigated, but indicates that STMPA had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.42%
ROE 4.84%
ROIC 3.12%
ROA(3y)15.52%
ROA(5y)12.31%
ROE(3y)23.34%
ROE(5y)19.28%
ROIC(3y)17.6%
ROIC(5y)15.93%
STMPA.PA Yearly ROA, ROE, ROICSTMPA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 7.65%, STMPA is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of STMPA has grown nicely.
STMPA has a worse Operating Margin (6.48%) than 79.63% of its industry peers.
In the last couple of years the Operating Margin of STMPA has grown nicely.
STMPA has a worse Gross Margin (32.96%) than 81.48% of its industry peers.
STMPA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.48%
PM (TTM) 7.65%
GM 32.96%
OM growth 3Y-10.78%
OM growth 5Y1.94%
PM growth 3Y3.75%
PM growth 5Y29.89%
GM growth 3Y-1.89%
GM growth 5Y1.17%
STMPA.PA Yearly Profit, Operating, Gross MarginsSTMPA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), STMPA is creating some value.
Compared to 1 year ago, STMPA has less shares outstanding
STMPA has more shares outstanding than it did 5 years ago.
STMPA has a worse debt/assets ratio than last year.
STMPA.PA Yearly Shares OutstandingSTMPA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
STMPA.PA Yearly Total Debt VS Total AssetsSTMPA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

STMPA has an Altman-Z score of 3.34. This indicates that STMPA is financially healthy and has little risk of bankruptcy at the moment.
STMPA's Altman-Z score of 3.34 is on the low side compared to the rest of the industry. STMPA is outperformed by 66.67% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that STMPA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.06, STMPA belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 3.34
ROIC/WACC0.31
WACC10.04%
STMPA.PA Yearly LT Debt VS Equity VS FCFSTMPA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

STMPA has a Current Ratio of 2.32. This indicates that STMPA is financially healthy and has no problem in meeting its short term obligations.
STMPA has a Current ratio (2.32) which is in line with its industry peers.
STMPA has a Quick Ratio of 1.66. This is a normal value and indicates that STMPA is financially healthy and should not expect problems in meeting its short term obligations.
STMPA has a Quick ratio (1.66) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.66
STMPA.PA Yearly Current Assets VS Current LiabilitesSTMPA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The earnings per share for STMPA have decreased strongly by -72.98% in the last year.
STMPA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.62% yearly.
STMPA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.57%.
Measured over the past years, STMPA shows a small growth in Revenue. The Revenue has been growing by 6.79% on average per year.
EPS 1Y (TTM)-72.98%
EPS 3Y-8.4%
EPS 5Y7.62%
EPS Q2Q%-84.21%
Revenue 1Y (TTM)-50.57%
Revenue growth 3Y1.31%
Revenue growth 5Y6.79%
Sales Q2Q%-14.42%

3.2 Future

The Earnings Per Share is expected to grow by 13.83% on average over the next years. This is quite good.
STMPA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.56% yearly.
EPS Next Y-61.84%
EPS Next 2Y-4.84%
EPS Next 3Y12.11%
EPS Next 5Y13.83%
Revenue Next Year-11%
Revenue Next 2Y0.11%
Revenue Next 3Y3.79%
Revenue Next 5Y6.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
STMPA.PA Yearly Revenue VS EstimatesSTMPA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
STMPA.PA Yearly EPS VS EstimatesSTMPA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.98, which means the current valuation is very expensive for STMPA.
The rest of the industry has a similar Price/Earnings ratio as STMPA.
Compared to an average S&P500 Price/Earnings ratio of 27.30, STMPA is valued at the same level.
With a Price/Forward Earnings ratio of 17.29, STMPA is valued on the expensive side.
62.96% of the companies in the same industry are more expensive than STMPA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.73. STMPA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 29.98
Fwd PE 17.29
STMPA.PA Price Earnings VS Forward Price EarningsSTMPA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, STMPA is valued cheaper than 87.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.95
STMPA.PA Per share dataSTMPA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as STMPA's earnings are expected to grow with 12.11% in the coming years.
PEG (NY)N/A
PEG (5Y)3.94
EPS Next 2Y-4.84%
EPS Next 3Y12.11%

6

5. Dividend

5.1 Amount

STMPA has a Yearly Dividend Yield of 1.62%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.36, STMPA pays a better dividend. On top of this STMPA pays more dividend than 81.48% of the companies listed in the same industry.
STMPA's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

The dividend of STMPA has a limited annual growth rate of 5.99%.
Dividend Growth(5Y)5.99%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

STMPA pays out 35.28% of its income as dividend. This is a sustainable payout ratio.
STMPA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP35.28%
EPS Next 2Y-4.84%
EPS Next 3Y12.11%
STMPA.PA Yearly Income VS Free CF VS DividendSTMPA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
STMPA.PA Dividend Payout.STMPA.PA Dividend Payout, showing the Payout Ratio.STMPA.PA Dividend Payout.PayoutRetained Earnings

STMICROELECTRONICS NV

EPA:STMPA (9/12/2025, 7:00:00 PM)

22.185

-0.09 (-0.38%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners30.25%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap20.22B
Analysts76.15
Price Target27.9 (25.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly Dividend0.27
Dividend Growth(5Y)5.99%
DP35.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)29.91%
Min EPS beat(2)-23.85%
Max EPS beat(2)83.68%
EPS beat(4)3
Avg EPS beat(4)18.9%
Min EPS beat(4)-23.85%
Max EPS beat(4)83.68%
EPS beat(8)6
Avg EPS beat(8)11.17%
EPS beat(12)9
Avg EPS beat(12)9.93%
EPS beat(16)12
Avg EPS beat(16)10.63%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-2.67%
Max Revenue beat(2)-1.5%
Revenue beat(4)0
Avg Revenue beat(4)-2.32%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)-1.5%
Revenue beat(8)0
Avg Revenue beat(8)-2.94%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.16%
PT rev (3m)5.24%
EPS NQ rev (1m)-10.75%
EPS NQ rev (3m)-28.07%
EPS NY rev (1m)-19.63%
EPS NY rev (3m)-19.63%
Revenue NQ rev (1m)0.43%
Revenue NQ rev (3m)3.99%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)3.01%
Valuation
Industry RankSector Rank
PE 29.98
Fwd PE 17.29
P/S 2
P/FCF N/A
P/OCF 8.81
P/B 1.26
P/tB 1.4
EV/EBITDA 5.95
EPS(TTM)0.74
EY3.34%
EPS(NY)1.28
Fwd EY5.78%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)2.52
OCFY11.35%
SpS11.1
BVpS17.55
TBVpS15.82
PEG (NY)N/A
PEG (5Y)3.94
Profitability
Industry RankSector Rank
ROA 3.42%
ROE 4.84%
ROCE 3.56%
ROIC 3.12%
ROICexc 4.22%
ROICexgc 4.77%
OM 6.48%
PM (TTM) 7.65%
GM 32.96%
FCFM N/A
ROA(3y)15.52%
ROA(5y)12.31%
ROE(3y)23.34%
ROE(5y)19.28%
ROIC(3y)17.6%
ROIC(5y)15.93%
ROICexc(3y)24.94%
ROICexc(5y)22.48%
ROICexgc(3y)26.67%
ROICexgc(5y)25.23%
ROCE(3y)20.08%
ROCE(5y)18.18%
ROICexcg growth 3Y-22.92%
ROICexcg growth 5Y-8.68%
ROICexc growth 3Y-21.32%
ROICexc growth 5Y-6.98%
OM growth 3Y-10.78%
OM growth 5Y1.94%
PM growth 3Y3.75%
PM growth 5Y29.89%
GM growth 3Y-1.89%
GM growth 5Y1.17%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 0.4
Cap/Depr 137.82%
Cap/Sales 24.1%
Interest Coverage 9.72
Cash Conversion 94.61%
Profit Quality N/A
Current Ratio 2.32
Quick Ratio 1.66
Altman-Z 3.34
F-Score6
WACC10.04%
ROIC/WACC0.31
Cap/Depr(3y)232.76%
Cap/Depr(5y)199.58%
Cap/Sales(3y)26.55%
Cap/Sales(5y)22.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.98%
EPS 3Y-8.4%
EPS 5Y7.62%
EPS Q2Q%-84.21%
EPS Next Y-61.84%
EPS Next 2Y-4.84%
EPS Next 3Y12.11%
EPS Next 5Y13.83%
Revenue 1Y (TTM)-50.57%
Revenue growth 3Y1.31%
Revenue growth 5Y6.79%
Sales Q2Q%-14.42%
Revenue Next Year-11%
Revenue Next 2Y0.11%
Revenue Next 3Y3.79%
Revenue Next 5Y6.56%
EBIT growth 1Y-86.42%
EBIT growth 3Y-9.61%
EBIT growth 5Y8.86%
EBIT Next Year46.94%
EBIT Next 3Y39.3%
EBIT Next 5Y26.74%
FCF growth 1Y-110.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.64%
OCF growth 3Y-1.17%
OCF growth 5Y8.75%